Lagis Enterprise Co., Ltd. (TPEX:6730)
Taiwan · Delayed Price · Currency is TWD 37.00
-0.45 (-1.20%)
At close: Feb 11, 2026
Lagis Enterprise Revenue
Lagis Enterprise had revenue of 126.40M TWD in the quarter ending September 30, 2025, with 8.81% growth. This brings the company's revenue in the last twelve months to 470.29M, up 0.06% year-over-year. In the year 2024, Lagis Enterprise had annual revenue of 454.36M, down -1.21%.
Revenue (ttm)
470.29M
Revenue Growth
+0.06%
P/S Ratio
2.86
Revenue / Employee
n/a
Employees
202
Market Cap
1.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 454.36M | -5.58M | -1.21% |
| Dec 31, 2023 | 459.93M | 17.75M | 4.01% |
| Dec 31, 2022 | 442.19M | 49.15M | 12.50% |
| Dec 31, 2021 | 393.04M | 73.68M | 23.07% |
| Dec 31, 2020 | 319.36M | -87.17M | -21.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.20B |
| Nang Kuang Pharmaceutical | 2.22B |
| Bionime | 1.91B |
| Chi Sheng Pharma & Biotech | 1.36B |
| ICARES Medicus | 1.09B |
| Crystalvue Medical | 905.73M |
| Concord Medical | 905.31M |
| Maxigen Biotech | 792.49M |